动脉血酮体比测定对中晚期肝癌栓塞化疗的临床应用研究

Study on Role of Arterial Blood Ketone Body Ratio Determination in Patients with Moderate and Advanced Liver Cancer Treated with Hepatic Artery Embolization and Chemotherapy

报告３０例中晚期肝癌在导管栓塞化疗前后进行的动脉血酮体比（ＡＫＢＲ）测定研究。结果表明，对肝癌实行明胶海绵和碘油乳剂栓塞化疗是目前行之有效的疗法。利用碘油乳剂适当栓塞对肝脏ＡＫＢＲ无明显影响，而明胶海绵需严格掌握适应证。ＡＫＢＲ的测定对中晚期肝癌的栓塞化疗中选用剂型、剂量及疗法上均有指导意义，对肝脏栓塞化疗前后肝脏能储的推测及肝功能衰竭的预测也颇有临床价值。

Arterial blood ketone body ratio (AKBR) was determined in 30cases of moderate and advanced hepatoma before and after hepatic artery infusion chemotherapy and embolization. Embolization with gelfoam or lipiodol emulsion is proved to be an effective treatment modality of hepatoma. Administration of lipiodol emulsion showed no significant influence on AKBR level which was decreased, however, in some cases when gelfoam was used. It is suggested that AKBR can be used as an indicator in the choice of embolization agents, dosage and technic of administration and, it is also useful in predicting hepatic energetic reserve.